Detalhe da pesquisa
1.
Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp Substrates in Patients With an Advanced Solid Tumor.
Clin Transl Sci
; 12(1): 58-65, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427584